$NBS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CALADRIUS BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CALADRIUS BIOSCIENCES, INC.. Get notifications about new insider transactions in CALADRIUS BIOSCIENCES, INC. for free.
Page: < prev 1 2 3 4 5 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 17 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Grant | A | 0.00 | 54,000 | 0 | 1,713,533 | 1.7 M to 1.7 M (+3.25 %) |
Jul 23 2012 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Gift | G | 0.00 | 15,306 | 0 | 22,545,180 | 22.5 M to 22.5 M (+0.07 %) |
Jul 23 2012 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Gift | G | 0.00 | 15,306 | 0 | 22,545,180 | 22.5 M to 22.5 M (+0.07 %) |
Jul 06 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Option Exercise | A | 0.52 | 700,000 | 364,000 | 700,000 | |
Jul 06 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Grant | A | 0.52 | 150,000 | 78,000 | 1,659,533 | 1.5 M to 1.7 M (+9.94 %) |
Jul 03 2012 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Grant | A | 0.49 | 7,652 | 3,749 | 1,819,709 | 1.8 M to 1.8 M (+0.42 %) |
Jul 03 2012 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Grant | A | 0.00 | 15,306 | 0 | 15,306 | 0 to 15.3 K |
Jul 03 2012 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Grant | A | 0.00 | 15,306 | 0 | 1,074,606 | 1.1 M to 1.1 M (+1.44 %) |
Jul 03 2012 | NBS | Caladrius Bioscien ... | GREENACRE MARTYN D | Director | Grant | A | 0.00 | 15,306 | 0 | 385,306 | 370 K to 385.3 K (+4.14 %) |
Jul 03 2012 | NBS | Caladrius Bioscien ... | Geehr Edward | Director | Option Exercise | A | 0.49 | 18,685 | 9,156 | 18,685 | |
Jul 03 2012 | NBS | Caladrius Bioscien ... | BERNSTEIN DREW | Director | Option Exercise | A | 0.49 | 18,685 | 9,156 | 18,685 | |
Jul 03 2012 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Grant | A | 0.00 | 15,306 | 0 | 185,306 | 170 K to 185.3 K (+9.00 %) |
Jun 27 2012 | NBS | Caladrius Bioscien ... | SCHMIEG MARTIN E | Vice President - Co ... | Option Exercise | A | 0.44 | 300,000 | 132,000 | 300,000 | |
Jun 27 2012 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Option Exercise | A | 0.44 | 64,583 | 28,417 | 64,583 | |
May 11 2012 | NBS | Caladrius Bioscien ... | GREENACRE MARTYN D | Director | Option Exercise | P | 0.51 | 250,000 | 127,500 | 250,000 | |
May 11 2012 | NBS | Caladrius Bioscien ... | GREENACRE MARTYN D | Director | Buy | P | 0.00 | 250,000 | 0 | 370,000 | 120 K to 370 K (+208.33 %) |
Apr 30 2012 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Option Exercise | A | 0.36 | 55,000 | 19,800 | 55,000 | |
Apr 30 2012 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Option Exercise | A | 0.36 | 58,025 | 20,889 | 58,025 | |
Apr 30 2012 | NBS | Caladrius Bioscien ... | May Larry Alan | Chief Financial Off ... | Option Exercise | A | 0.36 | 56,250 | 20,250 | 56,250 | |
Apr 30 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Option Exercise | A | 0.36 | 402,627 | 144,946 | 402,627 | |
Apr 30 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Grant | A | 0.36 | 24,872 | 8,954 | 1,509,553 | 1.5 M to 1.5 M (+1.68 %) |
Apr 30 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Option Exercise | A | 0.36 | 140,000 | 50,400 | 140,000 | |
Apr 30 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.36 | 7,536 | 2,713 | 2,021,518 | 2 M to 2 M (+0.37 %) |
Apr 16 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Grant | A | 0.32 | 8,478 | 2,713 | 2,013,982 | 2 M to 2 M (+0.42 %) |
Apr 16 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Grant | A | 0.33 | 26,313 | 8,683 | 1,484,681 | 1.5 M to 1.5 M (+1.80 %) |
Apr 04 2012 | NBS | Caladrius Bioscien ... | Sackner-Bernstein Jonathan | VP Clinical Dev & R ... | Option Exercise | A | 0.38 | 400,000 | 152,000 | 400,000 | |
Apr 03 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Grant | A | 0.38 | 21,653 | 8,228 | 1,458,368 | 1.4 M to 1.5 M (+1.51 %) |
Apr 02 2012 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Grant | A | 0.51 | 4,903 | 2,501 | 1,812,147 | 1.8 M to 1.8 M (+0.27 %) |
Mar 15 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Grant | A | 0.58 | 14,187 | 8,228 | 1,436,715 | 1.4 M to 1.4 M (+1.00 %) |
Mar 01 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.57 | 14,436 | 8,229 | 1,422,528 | 1.4 M to 1.4 M (+1.03 %) |
Feb 16 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.67 | 12,281 | 8,228 | 1,408,092 | 1.4 M to 1.4 M (+0.88 %) |
Feb 01 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.63 | 13,061 | 8,228 | 1,395,811 | 1.4 M to 1.4 M (+0.94 %) |
Jan 13 2012 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Gift | G | 0.00 | 120,000 | 0 | 22,529,874 | 22.4 M to 22.5 M (+0.54 %) |
Jan 13 2012 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Gift | G | 0.00 | 120,000 | 0 | 22,529,874 | 22.4 M to 22.5 M (+0.54 %) |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Shi Mingsheng | See Remarks | Option Exercise | A | 0.52 | 120,000 | 62,400 | 120,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | GREENACRE MARTYN D | Director | Grant | A | 0.00 | 120,000 | 0 | 120,000 | 0 to 120 K |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Geehr Edward | Director | Option Exercise | A | 0.52 | 120,000 | 62,400 | 120,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | BERNSTEIN DREW | Director | Option Exercise | A | 0.52 | 170,000 | 88,400 | 170,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Grant | A | 0.00 | 120,000 | 0 | 120,000 | 0 to 120 K |
Jan 06 2012 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Grant | A | 0.00 | 170,000 | 0 | 1,059,300 | 889.3 K to 1.1 M (+19.12 %) |
Jan 06 2012 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Grant | A | 0.00 | 170,000 | 0 | 170,000 | 0 to 170 K |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Talamo Joseph | See Remarks | Option Exercise | A | 0.52 | 75,000 | 39,000 | 75,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Kolbert Jason | See Remarks | Option Exercise | A | 0.52 | 125,000 | 65,000 | 125,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | A | 0.52 | 175,000 | 91,000 | 175,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Option Exercise | A | 0.52 | 150,000 | 78,000 | 150,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Option Exercise | A | 0.52 | 200,000 | 104,000 | 200,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Grant | A | 0.52 | 10,669 | 5,548 | 345,362 | 334.7 K to 345.4 K (+3.19 %) |
Jan 06 2012 | NBS | Caladrius Bioscien ... | May Larry Alan | Chief Financial Off ... | Option Exercise | A | 0.52 | 200,000 | 104,000 | 200,000 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Option Exercise | A | 0.52 | 276,400 | 143,728 | 276,400 | |
Jan 06 2012 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Option Exercise | A | 0.52 | 790,000 | 410,800 | 790,000 | |
Dec 19 2011 | NBS | Caladrius Bioscien ... | Kolbert Jason | See Remarks | Buy | P | 0.58 | 100 | 58 | 8,000 | 7.9 K to 8 K (+1.27 %) |
Dec 19 2011 | NBS | Caladrius Bioscien ... | Kolbert Jason | See Remarks | Buy | P | 0.59 | 2,900 | 1,699 | 7,900 | 5 K to 7.9 K (+58.00 %) |
Dec 15 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Buy | P | 0.60 | 10,000 | 6,000 | 2,005,504 | 2 M to 2 M (+0.50 %) |
Dec 15 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | Chief Medical Offic ... | Buy | P | 0.59 | 40,000 | 23,600 | 1,995,504 | 2 M to 2 M (+2.05 %) |
Dec 15 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Buy | P | 0.60 | 50,000 | 29,890 | 1,382,750 | 1.3 M to 1.4 M (+3.75 %) |
Dec 13 2011 | NBS | Caladrius Bioscien ... | Kolbert Jason | See Remarks | Buy | P | 0.59 | 2,900 | 1,718 | 5,000 | 2.1 K to 5 K (+138.10 %) |
Dec 13 2011 | NBS | Caladrius Bioscien ... | Kolbert Jason | See Remarks | Buy | P | 0.59 | 1,100 | 651 | 2,100 | 1,000 to 2.1 K (+110.00 %) |
Dec 13 2011 | NBS | Caladrius Bioscien ... | Kolbert Jason | See Remarks | Buy | P | 0.56 | 1,000 | 557 | 1,000 | 0 to 1,000 |
Oct 27 2011 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Option Exercise | J | 1.47 | 4,946 | 7,251 | 4,946 | |
Oct 27 2011 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Buy | J | 1.47 | 15,364 | 22,524 | 1,807,244 | 1.8 M to 1.8 M (+0.86 %) |
Nov 04 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.62 | 268,664 | 166,572 | 1,332,750 | 1.1 M to 1.3 M (+25.25 %) |
Nov 04 2011 | NBS | Caladrius Bioscien ... | May Larry Alan | Chief Financial Off ... | Grant | A | 0.62 | 21,500 | 13,330 | 63,118 | 41.6 K to 63.1 K (+51.66 %) |
Oct 27 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | J | 1.47 | 10,575 | 15,503 | 10,575 | |
Oct 27 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Buy | J | 1.47 | 32,852 | 48,161 | 1,955,504 | 1.9 M to 2 M (+1.71 %) |
Oct 04 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.69 | 12,311 | 8,495 | 1,064,086 | 1.1 M to 1.1 M (+1.17 %) |
Sep 19 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.65 | 13,926 | 9,052 | 1,051,775 | 1 M to 1.1 M (+1.34 %) |
Aug 31 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.73 | 11,637 | 8,495 | 1,037,849 | 1 M to 1 M (+1.13 %) |
Aug 19 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | A | 0.71 | 500,000 | 355,000 | 500,000 | |
Aug 16 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.64 | 14,143 | 9,052 | 1,026,212 | 1 M to 1 M (+1.40 %) |
Aug 02 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 0.85 | 9,994 | 8,495 | 1,012,069 | 1 M to 1 M (+1.00 %) |
Jul 01 2011 | NBS | Caladrius Bioscien ... | Talamo Joseph | See Remarks | Option Exercise | A | 1.43 | 325,000 | 464,750 | 325,000 | |
May 17 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 1.67 | 5,111 | 8,535 | 1,002,075 | 997 K to 1 M (+0.51 %) |
May 03 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 1.98 | 3,967 | 7,855 | 996,964 | 993 K to 997 K (+0.40 %) |
May 03 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 1.99 | 4,206 | 8,370 | 992,997 | 988.8 K to 993 K (+0.43 %) |
Apr 06 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Option Exercise | A | 1.74 | 1,500,000 | 2,610,000 | 1,500,000 | |
Apr 06 2011 | NBS | Caladrius Bioscien ... | Zhang Ian | See Remarks | Option Exercise | A | 1.74 | 250,000 | 435,000 | 250,000 | |
Apr 06 2011 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Option Exercise | A | 1.74 | 250,000 | 435,000 | 250,000 | |
Apr 06 2011 | NBS | Caladrius Bioscien ... | HARRIS ALAN G | See Remarks | Option Exercise | A | 1.74 | 150,000 | 261,000 | 150,000 | |
Apr 06 2011 | NBS | Caladrius Bioscien ... | May Larry Alan | Chief Financial Off ... | Option Exercise | A | 1.74 | 350,000 | 609,000 | 350,000 | |
Apr 04 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 1.68 | 4,675 | 7,854 | 988,791 | 984.1 K to 988.8 K (+0.48 %) |
Mar 17 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of Board a ... | Grant | A | 1.58 | 5,297 | 8,369 | 984,116 | 978.8 K to 984.1 K (+0.54 %) |
Mar 10 2011 | NBS | Caladrius Bioscien ... | Geehr Edward | Director | Option Exercise | A | 1.82 | 115,000 | 209,300 | 115,000 | |
Mar 08 2011 | NBS | Caladrius Bioscien ... | Kolbert Jason | See Remarks | Option Exercise | A | 1.49 | 350,000 | 521,500 | 350,000 | |
Mar 04 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Buy | P | 1.28 | 78,125 | 100,000 | 1,922,652 | 1.8 M to 1.9 M (+4.24 %) |
Mar 04 2011 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Buy | P | 1.28 | 195,313 | 250,001 | 195,313 | 0 to 195.3 K |
Mar 04 2011 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Buy | P | 1.28 | 195,312 | 249,999 | 889,300 | 694 K to 889.3 K (+28.14 %) |
Mar 02 2011 | NBS | Caladrius Bioscien ... | Smith Robin L | Chairman of the Boa ... | Buy | P | 1.28 | 6,136 | 7,854 | 978,819 | 972.7 K to 978.8 K (+0.63 %) |
Jan 21 2011 | NBS | Caladrius Bioscien ... | Preti Robert A | See Remarks | Option Exercise | A | 1.50 | 400,000 | 600,000 | 400,000 | |
Jan 21 2011 | NBS | Caladrius Bioscien ... | Pecora Andrew L | See Remarks | Option Exercise | A | 1.50 | 400,000 | 600,000 | 400,000 | |
Dec 17 2010 | NBS | Caladrius Bioscien ... | Zhang Ian | See Remarks | Option Exercise | A | 1.42 | 150,000 | 213,000 | 150,000 | |
Sep 03 2010 | NBS | Caladrius Bioscien ... | Zhang Ian | See Remark (1) | Option Exercise | A | 1.65 | 600,000 | 990,000 | 600,000 | |
Sep 03 2010 | NBS | Caladrius Bioscien ... | Zhang Ian | See Remark (1) | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Aug 20 2010 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Sell | S | 1.50 | 80,000 | 120,000 | 0 | 80 K to 0 (-100.00 %) |
Jul 16 2010 | NBS | Caladrius Bioscien ... | HARRIS ALAN G | See Remarks | Option Exercise | A | 1.68 | 150,000 | 252,000 | 150,000 | |
Aug 20 2010 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Buy | P | 1.50 | 80,000 | 120,000 | 693,988 | 614 K to 694 K (+13.03 %) |
Jul 09 2010 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Option Exercise | A | 1.75 | 350,000 | 612,500 | 350,000 | |
Jun 18 2010 | NBS | Caladrius Bioscien ... | Shi Mingsheng | See Remark No 1. be ... | Option Exercise | A | 2.36 | 600,000 | 1,416,000 | 600,000 | |
Jun 11 2010 | NBS | Caladrius Bioscien ... | Salerno Anthony | See Remarks | Option Exercise | A | 2.16 | 300,000 | 648,000 | 300,000 | |
Jun 11 2010 | NBS | Caladrius Bioscien ... | Zhang Jian M | See Remarks | Option Exercise | A | 2.16 | 650,000 | 1,404,000 | 650,000 | |
Jun 02 2010 | NBS | Caladrius Bioscien ... | Zhang Jian M | See Remarks | Option Exercise | X | 1.75 | 400,000 | 700,000 | 0 | |
Jun 02 2010 | NBS | Caladrius Bioscien ... | Zhang Jian M | See Remarks | Buy | X | 1.75 | 400,000 | 700,000 | 3,650,770 | 3.3 M to 3.7 M (+12.30 %) |
May 19 2010 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Option Exercise | C | 0.90 | 8,177,512 | 7,359,761 | 0 | |
May 19 2010 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Buy | C | 0.90 | 9,086,124 | 8,177,512 | 22,409,874 | 13.3 M to 22.4 M (+68.19 %) |
Jun 02 2010 | NBS | Caladrius Bioscien ... | Shi Mingsheng | See Remarks | Option Exercise | X | 1.75 | 400,000 | 700,000 | 0 | |
Jun 02 2010 | NBS | Caladrius Bioscien ... | Shi Mingsheng | See Remarks | Buy | X | 1.75 | 400,000 | 700,000 | 3,650,770 | 3.3 M to 3.7 M (+12.30 %) |
May 19 2010 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Option Exercise | C | 0.90 | 8,177,512 | 7,359,761 | 0 | |
May 19 2010 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Buy | C | 0.90 | 9,086,124 | 8,177,512 | 22,409,874 | 13.3 M to 22.4 M (+68.19 %) |
Apr 28 2010 | NBS | Caladrius Bioscien ... | Fullbright Finance Ltd | 10% Owner | Buy | P | 0.00 | 203,338 | 0 | 3,250,770 | 3 M to 3.3 M (+6.67 %) |
Apr 28 2010 | NBS | Caladrius Bioscien ... | Shi Mingsheng | 10% Owner | Buy | J | 0.00 | 203,338 | 0 | 3,250,770 | 3 M to 3.3 M (+6.67 %) |
Apr 28 2010 | NBS | Caladrius Bioscien ... | Shi Mingsheng | 10% Owner | Buy | J | 0.00 | 175,000 | 0 | 175,000 | 0 to 175 K |
Apr 28 2010 | NBS | Caladrius Bioscien ... | Zhang Jian M | See Remarks | Buy | J | 0.00 | 203,338 | 0 | 3,250,770 | 3 M to 3.3 M (+6.67 %) |
Apr 28 2010 | NBS | Caladrius Bioscien ... | Zhang Jian M | See Remarks | Grant | A | 0.00 | 175,000 | 0 | 175,000 | 0 to 175 K |
Mar 18 2010 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Option Exercise | O | 1.75 | 1,000,000 | 1,750,000 | 0 | |
Mar 18 2010 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Buy | O | 1.75 | 1,000,000 | 1,750,000 | 13,323,750 | 12.3 M to 13.3 M (+8.11 %) |
Mar 01 2010 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | P | 6.18 | 85,228 | 526,709 | 85,228 | |
Feb 22 2010 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Buy | P | 1.35 | 740,741 | 1,000,000 | 12,323,750 | 11.6 M to 12.3 M (+6.40 %) |
Feb 22 2010 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Gift | G | 0.00 | 125,000 | 0 | 11,583,009 | 11.5 M to 11.6 M (+1.09 %) |
Mar 18 2010 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Option Exercise | O | 1.75 | 1,000,000 | 1,750,000 | 0 | |
Mar 18 2010 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Buy | O | 1.75 | 1,000,000 | 1,750,000 | 13,323,750 | 12.3 M to 13.3 M (+8.11 %) |
Feb 22 2010 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Buy | P | 1.35 | 740,741 | 1,000,000 | 12,323,750 | 11.6 M to 12.3 M (+6.40 %) |
Feb 22 2010 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Gift | G | 0.00 | 125,000 | 0 | 11,583,009 | 11.5 M to 11.6 M (+1.09 %) |
Feb 22 2010 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Buy | P | 1.35 | 200,000 | 270,000 | 613,988 | 414 K to 614 K (+48.31 %) |
Jan 08 2010 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Sell | S | 1.09 | 137,728 | 150,124 | 80,000 | 217.7 K to 80 K (-63.26 %) |
Jan 08 2010 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Buy | P | 1.09 | 137,728 | 150,124 | 413,988 | 276.3 K to 414 K (+49.85 %) |
Dec 02 2009 | NBS | Caladrius Bioscien ... | DUIGNAN CHRISTOPHER C | Vice President, Fin ... | Option Exercise | A | 1.72 | 250,000 | 430,000 | 250,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | VACZY CATHERINE M | VP and General Coun ... | Option Exercise | A | 1.66 | 100,000 | 166,000 | 100,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | BERNSTEIN DREW | Director | Option Exercise | A | 1.66 | 50,000 | 83,000 | 50,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | BERNSTEIN DREW | Director | Option Exercise | A | 1.66 | 150,000 | 249,000 | 150,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | A | 1.66 | 50,000 | 83,000 | 50,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | A | 1.66 | 150,000 | 249,000 | 150,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Option Exercise | A | 1.66 | 50,000 | 83,000 | 50,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Option Exercise | A | 1.66 | 150,000 | 249,000 | 150,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | MYERS STEVEN S | Director | Grant | A | 0.00 | 100,000 | 0 | 276,260 | 176.3 K to 276.3 K (+56.73 %) |
Nov 06 2009 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Option Exercise | A | 1.66 | 50,000 | 83,000 | 50,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Option Exercise | A | 1.66 | 150,000 | 249,000 | 150,000 | |
Nov 06 2009 | NBS | Caladrius Bioscien ... | BERMAN RICHARD J | Director | Grant | A | 0.00 | 80,000 | 0 | 217,728 | 137.7 K to 217.7 K (+58.09 %) |
Nov 06 2009 | NBS | Caladrius Bioscien ... | Wei Eric | Director | Option Exercise | A | 1.66 | 150,000 | 249,000 | 150,000 | |
Nov 03 2009 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Option Exercise | J | 2.50 | 4,000,000 | 10,000,000 | 4,000,000 | |
Nov 03 2009 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Option Exercise | C | 0.00 | 400,000 | 0 | 0 | |
Nov 03 2009 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Option Exercise | C | 0.90 | 8,177,512 | 7,359,761 | 8,177,512 | |
Nov 03 2009 | NBS | Caladrius Bioscien ... | RimAsia Capital Partners, L.P. | Director | Buy | P | 0.00 | 10,458,009 | 0 | 11,458,009 | 1000 K to 11.5 M (+1,045.80 %) |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | A | 1.90 | 229,678 | 436,388 | 229,678 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | A | 1.90 | 100,000 | 190,000 | 100,000 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | D | 4.95 | 100,000 | 495,000 | 0 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | A | 1.90 | 150,000 | 285,000 | 150,000 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | D | 4.95 | 150,000 | 742,500 | 0 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | A | 1.90 | 55,000 | 104,500 | 55,000 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | D | 5.00 | 55,000 | 275,000 | 0 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | A | 1.90 | 5,000 | 9,500 | 5,000 | |
Nov 02 2009 | NBS | Caladrius Bioscien ... | Smith Robin L | CEO and Chairman of ... | Option Exercise | D | 6.00 | 5,000 | 30,000 | 0 |